Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #7474
Reference
Drug alert 32/2021
Name
Drug alert class 4 no. 32 2021 - Caution in Use – Mawdsley-Brooks & Company Limited, Medicines Defect Information: Diuril Oral Solution (unlicensed medicine)
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
Description
Mawdsley-Brooks & Company Limited have notified of an error with the patient information leaflet (PIL) that has been provided with the above batches of products. The PIL provided was a newer version of the PIL which did not include the correct ingredient information.
Contact Name
Contact Email
Contact Address
Contact Phone
Created
2021-11-29 00:00:00
Click to go back to homepage